Spots Global Cancer Trial Database for melanoma (skin)
Every month we try and update this database with for melanoma (skin) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | NCT00004135 | Kidney Cancer Melanoma (Skin) | filgrastim therapeutic all... cyclophosphamid... fludarabine pho... peripheral bloo... | 18 Years - 65 Years | University of Chicago | |
| Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma | NCT00091143 | Melanoma (Skin) | gp100 antigen incomplete Freu... keyhole limpet ... fludarabine pho... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma | NCT00053781 | Melanoma (Skin) | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain | NCT00039572 | Brain and Centr... Melanoma (Skin) Metastatic Canc... | boronophenylala... | 18 Years - | National Cancer Institute (NCI) | |
| Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy | NCT00897520 | Melanoma (Skin) | recombinant int... proteomic profi... immunoenzyme te... laboratory biom... | - 120 Years | Eastern Cooperative Oncology Group | |
| Irofulven in Treating Patients With Stage IV Melanoma | NCT00005968 | Melanoma (Skin) | irofulven | 18 Years - | University of Colorado, Denver | |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00056134 | Melanoma (Skin) | Dendritic cell ... | 18 Years - 120 Years | University Hospital Erlangen | |
| Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | NCT00003601 | Melanoma (Skin) | fenretinide tretinoin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma | NCT00089193 | Melanoma (Skin) | incomplete Freu... multi-epitope m... sargramostim | 12 Years - | University of Virginia | |
| Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00007969 | Melanoma (Skin) | Detox-B adjuvan... verteporfin | 18 Years - | National Cancer Institute (NCI) | |
| Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma | NCT00514085 | Melanoma (Skin) | recombinant hum... immunohistochem... laboratory biom... pharmacological... | 18 Years - | Canadian Cancer Trials Group | |
| Biological Therapy in Treating Patients With Metastatic Melanoma | NCT00045149 | Melanoma (Skin) | aldesleukin therapeutic tum... | 18 Years - 75 Years | Fred Hutchinson Cancer Center | |
| ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma | NCT00081042 | Melanoma (Skin) | paclitaxel albu... | 18 Years - | National Cancer Institute (NCI) | |
| Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2 | NCT03233828 | Melanoma (Skin) Melanoma in Sit... | Aldesleukin Saline | 18 Years - 80 Years | Nova Scotia Health Authority | |
| Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC | NCT03291002 | Melanoma (Skin) Squamous Cell C... Carcinoma, Squa... Carcinoma, Aden... | CV8102 CV8102 + anti-P... | 18 Years - | CureVac | |
| Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients | NCT03224208 | Melanoma Melanoma (Skin) Melanoma Stage | Vemurafenib Cobimetinib | 18 Years - | Fondazione Melanoma Onlus | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma | NCT00002669 | Melanoma (Skin) | aldesleukin recombinant int... cisplatin dacarbazine | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma | NCT00003222 | Melanoma (Skin) | aldesleukin gp100 antigen incomplete Freu... sargramostim tetanus peptide... tyrosinase pept... | 18 Years - 79 Years | University of Virginia | |
| Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma | NCT00005057 | Melanoma (Skin) | adenovirus RSV-... ganciclovir | 18 Years - | National Cancer Institute (NCI) | |
| Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | NCT00020540 | Kidney Cancer Melanoma (Skin) | recombinant CD4... recombinant flt... | 16 Years - | National Cancer Institute (NCI) | |
| Nevus Doctor Clinical Decision Support for GPs | NCT03246412 | Melanoma (Skin) Non-melanoma Sk... Actinic Keratos... | Nevus doctor cl... | 18 Years - 120 Years | University Hospital of North Norway | |
| Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma | NCT00077532 | Melanoma (Skin) | gp100 antigen incomplete Freu... ipilimumab | 16 Years - | National Institutes of Health Clinical Center (CC) | |
| Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery | NCT00450372 | Melanoma (Skin) | ADI-PEG-20 Pharmacology St... | 18 Years - 120 Years | University of Miami | |
| Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions | NCT00391300 | Melanoma (Skin) Non-melanomatou... | bioelectric fie... biopsy histopathologic... | 18 Years - | National Cancer Institute (NCI) | |
| Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma | NCT00062036 | Melanoma (Skin) | aldesleukin filgrastim incomplete Freu... interleukin-2 g... therapeutic tum... cyclophosphamid... fludarabine pho... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Reflectance Confocal Microscopy to Diagnose MM & LM | NCT03508297 | Melanoma (Skin) Lentigo Maligna | In-vivo imaging | 18 Years - | Skin Care Network Ltd. | |
| Passive Versus Active Educational Interventions for Melanoma Recognition | NCT04507048 | Educational Pro... Melanoma (Skin) | Active educatio... Passive educati... | 18 Years - 75 Years | Azienda Unità Sanitaria Locale Reggio Emilia | |
| Safety and Avoidance of Futile Excisions Through Skin Tele-triage | NCT05982600 | Melanoma (Skin) Telemedicine | Single Assessor... 2 people Telede... 3 people Telede... 5 people Telede... | 18 Years - 80 Years | Herlev Hospital | |
| Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma | NCT00074230 | Melanoma (Skin) | Autologous Dend... | 18 Years - | University Hospital Erlangen | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma | NCT00004025 | Melanoma (Skin) | aldesleukin dendritic cell-... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma | NCT00019994 | Melanoma (Skin) | MART-1 antigen aldesleukin gp100 antigen incomplete Freu... | 16 Years - | National Cancer Institute (NCI) | |
| START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer | NCT05492682 | Melanoma (Skin) Triple-Negative... Non-Small Cell ... Synovial Sarcom... Myxoid Liposarc... Colorectal Canc... | PeptiCRAd-1 Cyclophosphamid... Pembrolizumab | 18 Years - | Valo Therapeutics Oy | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | NCT00004244 | Kidney Cancer Melanoma (Skin) | recombinant int... recombinant int... | 18 Years - | National Cancer Institute (NCI) | |
| High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma | NCT00003641 | Melanoma (Skin) | interferon alfa... observation | 18 Years - | Eastern Cooperative Oncology Group | |
| Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma | NCT00512798 | Brain and Centr... Melanoma Solid Tumor | PS-341 (VELCADE... temozolomide immunoenzyme te... PS-341 (VELCADE... Temozolomide | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients | NCT04200040 | Melanoma (Skin) | OrienX010 injec... Dacarbazine (DT... | 18 Years - 70 Years | OrienGene Biotechnology Ltd. | |
| 0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma | NCT00729807 | Melanoma (Skin) | pentamidine | 18 Years - 120 Years | University of Maryland, Baltimore | |
| Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | NCT00002892 | Melanoma (Skin) | recombinant int... | - | National Cancer Institute (NCI) | |
| Exercise and Diet Interventions During Immunotherapy in Melanoma Patients | NCT06298734 | Melanoma (Skin) Skin Cancer Advanced Melano... | Exercise Progra... Diet Program | 18 Years - | Dana-Farber Cancer Institute | |
| Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control | NCT00295906 | Melanoma (Skin) Non-melanomatou... | educational int... internet-based ... | 18 Years - | National Cancer Institute (NCI) | |
| Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma | NCT00471887 | Melanoma (Skin) | CP-675,206 | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma | NCT00324623 | Melanoma (Skin) | Melan-A VLP vac... adoptive immuno... therapeutic aut... cyclophosphamid... fludarabine pho... | 18 Years - 75 Years | Centre Hospitalier Universitaire Vaudois | |
| SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer | NCT03294330 | Sentinel Lymph ... Melanoma (Skin) Breast Cancer | IC-Green KIT | 18 Years - | Milton S. Hershey Medical Center | |
| Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma | NCT05307289 | Melanoma (Skin) | Biposy | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00085397 | Melanoma (Skin) | autologous dend... gp100 antigen therapeutic aut... | - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00004184 | Melanoma (Skin) | monoclonal anti... sargramostim alum adjuvant | 18 Years - | University of Alabama at Birmingham | |
| High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma | NCT00003091 | Kidney Cancer Melanoma (Skin) | aldesleukin recombinant int... | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| New Tumor Models in Three Dimensions and in a Human Skin Environment for Personalized Melanoma Therapy | NCT03136783 | Melanoma (Skin) | Development of ... | 18 Years - | Centre Hospitalier Universitaire, Amiens | |
| FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) | NCT05432193 | Pancreatic Duct... Colorectal Canc... Esophageal Canc... Melanoma (Skin) Soft Tissue Sar... Head and Neck S... Cholangiocarcin... | [Ga-68]-PNT6555 [Lu-177]-PNT655... | 18 Years - | POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | |
| Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma | NCT00357461 | Melanoma (Skin) | gp100:209-217(2... gp100:280-288(2... incomplete Freu... ipilimumab | 16 Years - | Bristol-Myers Squibb | |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma | NCT00089193 | Melanoma (Skin) | incomplete Freu... multi-epitope m... sargramostim | 12 Years - | University of Virginia | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms | NCT05402046 | Melanoma (Skin) Nevus Nevus, Spitz Nevus Halo Nevus, Pigmente... Basal Cell Carc... Squamous Cell C... Bowen's Disease Melanoma in Sit... Spot Pigmented | Mobile phone ap... | 18 Years - | MelanomaPRO, Russia | |
| Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma | NCT00512889 | Melanoma (Skin) | therapeutic aut... Use of an artif... GM-CSF Irradiation of ... | 18 Years - | Dana-Farber Cancer Institute | |
| Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma | NCT00602576 | Melanoma (Skin) | sorafenib tosyl... temozolomide | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00003346 | Melanoma (Skin) | acetaminophen acetylcysteine carmustine | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma | NCT00006233 | Melanoma (Skin) | therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | 18 Years - 64 Years | Fred Hutchinson Cancer Center | |
| Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma | NCT00863330 | Melanoma (Skin) | Tumor Infiltrat... | 18 Years - | Aurora Health Care | |
| PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma | NCT00049530 | Melanoma (Skin) | PEG-interferon ... | 18 Years - | Eastern Cooperative Oncology Group | |
| SCIB1 in Melanoma Patients Receiving Either Nivolumab With Ipilimumab or Pembrolizumab (The SCOPE Study) | NCT04079166 | Malignant Melan... Melanoma (Skin) Melanoma Stage ... Melanoma Stage ... | SCIB1 DNA vacci... | 18 Years - | Scancell Ltd | |
| Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial | NCT00316901 | Kidney Cancer Melanoma (Skin) | computed tomogr... positron emissi... fludeoxyglucose... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Melanoma Patients Immunized With Natural DenDritic Cells | NCT02993315 | Melanoma (Skin) | nDC vaccination placebo injecti... | 18 Years - | Radboud University Medical Center | |
| Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | NCT00404235 | Melanoma (Skin) | carboplatin paclitaxel albu... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | NCT00453050 | Melanoma (Skin) Metastatic Canc... | imiquimod indocyanine gre... flow cytometry immunologic tec... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma | NCT00863330 | Melanoma (Skin) | Tumor Infiltrat... | 18 Years - | Aurora Health Care | |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment | NCT00022438 | Melanoma (Skin) | aldesleukin incomplete Freu... recombinant tyr... | 16 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal | NCT00003229 | Melanoma (Skin) | aldesleukin gp100 antigen tyrosinase pept... | 18 Years - 75 Years | Duke University | |
| Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma | NCT01018004 | Melanoma (Skin) | follow-up care questionnaire a... quality-of-life... | 18 Years - 85 Years | National Cancer Institute (NCI) | |
| E7070 in Treating Patients With Stage IV Melanoma | NCT00014625 | Melanoma (Skin) | indisulam | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Zr89 + PET Companion Trial | NCT05279027 | Melanoma (Skin) | Zirconium Zr 89... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma | NCT00049010 | Melanoma (Skin) | comparative gen... cytogenetic ana... fluorescence in... immunohistochem... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery | NCT00521001 | Melanoma (Skin) | everolimus temozolomide | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
